Genetics is the future. The things that scientists have been able to do to switch these new technologies have been pretty stunning. Gene editing can make people and animals stronger, taller, or impervious to disease. And we're only at the start of this revolution. This sector certainly has plenty of room to expand and become more advanced. As one of the leading companies in this sector, Fulgent has a lot of room to grow. Since capping off, shares have fallen over 40%, and they have managed to form a reverse head and shoulders and a cup and handle pattern. These bullish signs tell me it is time to get in on this company. I think $FLGT could easily be worth $300+ in the upcoming years. I love this company and chart. Good Luck!
